Paul V Maier
Director · 6 filings · Latest: Sep 16, 2026
Eton Pharmaceuticals, Inc.
International Stem Cell CORP
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ISCO | Paul V Maier | Director | Sep 11, 2026 | Sale | $0.32 | 32,802 | $10.5K | 0 | |
ISCO | MAIER PAUL V | — | Sep 11, 2026 | Proposed Sale | $0.36 | 32,802 | $11.8K | — | |
ETON | Paul V Maier | Director | Aug 28, 2026 | Sale | $59.07 | 50,000 | $3.0M | 59,745 | |
ETON | Paul V Maier | Director | Aug 28, 2026 | Option Exercise | $4.49 | 62,500 | $280.4K | 72,245 | |
ETON | Paul V Maier | Director | Aug 28, 2026 | Sale | $59.07 | 50,000 | $3.0M | 59,745 | |
ETON | Paul V Maier | Director | Aug 28, 2026 | Option Exercise | $3.78 | 50,000 | $189.0K | 109,745 | |
ETON | MAIER PAUL V | — | Aug 28, 2026 | Proposed Sale | $59.07 | 50,000 | $3.0M | — |